Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

This study aimed to evaluate treatment outcomes and safety of afatinib in patients with squamous cell carcinoma of the lung (LSCC) who progressed after chemotherapy and immunotherapy. We recruited patients both retrospectively and prospectively and collected the outcomes and safety data. Additionall...

Full description

Bibliographic Details
Main Authors: Wonjun Ji, In-Jae Oh, Cheol-Kyu Park, Sung Yong Lee, Juwhan Choi, Jae Cheol Lee, Jiwon Kim, Seung Hyeun Lee
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
afatinib
squamous cell carcinoma
chemotherapy
immunotherapy
molecular profile
predictive biomarkers
Online Access:https://www.mdpi.com/2072-6694/15/23/5568

Internet

https://www.mdpi.com/2072-6694/15/23/5568

Similar Items